| Novo Nordisk Pharma AG - NovoSeven 8 mg, raumtemperaturstabiles Injektionspräparat | | 58693 | | 04 | | NovoSeven 8 mg | | raumtemperaturstabiles Injektionspräparat | | B02BD08 | | Eptacog alfa (aktiviert) | | 12.03.2012 | | |
| | Composition | | Praeparatio cryodesiccata: eptacogum alfa (activatum) 8 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 4 mg, pro vitro.
Solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 8.3 ml.
Solutio reconstituta: eptacogum alfa (activatum) 8 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 8 ml. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | Preparation injectable, stable à température ambiante | | | | | | Principe actif | Concentr. |
|---|
| Eptacog Alfa | 8 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Calcium Chlorure | | | | Glycyl-Glycinum | | | | Mannitol | | | | Methionine | 4 mg | antiox. | | Sodium Chlorure | | | | Polysorbatum 80 | | | | Saccharum | | |
|
| Solvens | | Preparation injectable, stable à température ambiante | | | | | | | | | Agents auxilliaires |
|---|
| Histidine |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 008 | Set(s) | DDP | DDP | B | | Oui |
|
|
